Saint Xiang Biotech: plans to jointly invest 370 million yuan with professional institutions to establish a fund.

Shengxiang Biology announced that the company plans to establish the Hunan Jin Furong Shengxiang Biology Fund with partners such as Changsha Shengwei Rongquan Entrepreneurship Investment Co., Ltd., with a target fundraising size of 1 billion yuan. Among them, the company plans to subscribe to 370 million yuan as a limited partner, with a contribution ratio of 37%. This fund will invest in AI medical applications, innovative medical devices, and other medical industry enterprises. This investment will not be included in the company's consolidated financial statements, the risk exposure will not exceed the amount of the subscribed capital, and it will not affect the company's normal operation. This proposal will be put to a vote at the extraordinary shareholder meeting on November 17, 2025.